gene 2,573 words KG: PON2
Contents

PON2 (Paraoxonase 2)

🧬 Gene Info
Gene SymbolPON2
Full NameParaoxonase 2
Chromosome7q21.3
Primary Expressionthe liver and secreted into the plasma, PON2 exhibits a broader tissue distribution with particularly high expression in the brain, lung, and heart
Subcellular Localizationpositions PON2 at critical intersections of cellular metabolism, where it exerts potent antioxidant, anti-apoptotic, and
Amino Acids354 aa
UniProt ID[Q15165](https://www.uniprot.org/uniprot/Q15165)
Ensembl IDENSG00000105855
GeneCardsPON2
Human Protein AtlasPON2
N-terminal signal sequenceUnlike secreted PON1 and PON3, PON2 lacks a classical secretory signal peptide, explaining its intracellular retention.
N-terminal hydrophobic domainA hydrophobic N-terminal region anchors PON2 to intracellular membranes, particularly the endoplasmic reticulum and mitochondrial outer membrane.
N-glycosylation sitesPON2 contains multiple N-linked glycosylation sites that are important for proper folding and stability.
Lactonase active siteThe canonical paraoxonase active site comprises a lactonase domain that hydrolyzes a broad range of substrates.
Conserved serine hydrolase motifA serine-lysine-histidine catalytic triad typical of the paraoxonase family.
Associated Diseasesneurodegeneration
KG Connections1 knowledge graph edges
DatabasesGeneCardsNCBI GeneHPASTRING

Knowledge Graph

Related Hypotheses (13)

Chromatin Accessibility Restoration via BRD4 Modulation
Score: 0.56
Epigenetic Memory Erasure via TET2 Activation
Score: 0.52
Astrocyte-Mediated Neuronal Epigenetic Rescue
Score: 0.48
TET2-Mediated Demethylation Rejuvenation Therapy
Score: 0.47
Temporal TET2-Mediated Hydroxymethylation Cycling
Score: 0.41

Related Analyses (4)

Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived
Epigenetic reprogramming in aging neurons
neurodegeneration · archived
Circuit-level neural dynamics in neurodegeneration
neuroscience · archived

Related Experiments (5)

Anti-Tau Antibody vs ASO/Gene Therapy — Comparative Efficacy
validation · proposed · Score: 0.40
cGAS-STING Pathway Validation Study in Parkinson's Disease
clinical · proposed · Score: 0.40
DNA Damage Repair Deficiency Validation Study in Parkinson's
clinical · proposed · Score: 0.40
AAV-LRRK2 Gene Therapy IND-Enabling Study Design
clinical · proposed · Score: 0.40
Non-Motor Symptom Progression in Parkinson's Disease — Mecha
clinical · proposed · Score: 0.40

See Also (1)

Neurodegeneration
disease · KG edge: implicated_in

Knowledge Graph (1 edges)

PON2 participates_in oxidative stress response